JPRN-jRCT2031210708招募中1 期
Phase I study of CBA-1535
Tanaka Miseri0 个研究点目标入组 70 人开始时间: 2022年3月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •ECOG performance status: <= 1
- •- Patients with 3 months or longer life expectancy
排除标准
- •- Patients who received other investigational drug or antibody drugs, including immune checkpoint inhibitor within 28 days prior to enrollment
- •- Patients who received anti-cancer drug within 14 days prior to enrollment
研究者
相似试验
招募中
1 期
Phase I study of CBA-1205JPRN-jRCT2080225288Chiome Bioscience Inc.41
进行中（未招募）
不适用
Protocol CA180015: A Phase II Study of BMS-354825 in Subjects with Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib MesylateEUCTR2004-002517-36-ITBRISTOL-M.SQUIBB
招募中
2 期
A phase II study of NPC-15 on difficulty initiating sleep in patients with mild cognitive impairmentJapanese patients with mild cognitive impairment who has difficulty initiating sleepJPRN-jRCT2071230029Motomura Tomoko120
招募中
2 期
A phase II study of NPC-15 on difficulty initiating sleep in patients with dementiaJapanese patients with dementia who has difficulty initiating sleepJPRN-jRCT2071230030Motomura Tomoko120
已完成
Unknown
Phase 1 trial: CA38951Healthy volunteersISRCTN46343886Millicent Pharma Limited36